Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Fake news and clickbait - natural enemies of evidence-based medicine.

Bolton DM, Yaxley J.

BJU Int. 2017 May;119 Suppl 5:8-9. doi: 10.1111/bju.13883. No abstract available.

PMID:
28544296
2.

Confusion, Faciobrachial Dystonic Seizures, and Critical Hyponatremia in a Patient with Voltage-Gated Potassium Channel Encephalitis.

Yaxley J.

Korean J Fam Med. 2017 Mar;38(2):99-101. doi: 10.4082/kjfm.2017.38.2.99. Epub 2017 Mar 22.

3.
4.
5.

Assessing robot-assisted laparoscopic prostatectomy - Authors' reply.

Yaxley JW, Coughlin GD, Chambers SK, Dunglison N, Gardiner RA.

Lancet. 2017 Feb 25;389(10071):800-801. doi: 10.1016/S0140-6736(17)30508-1. No abstract available.

PMID:
28248170
6.

Urinary tract cancers: An overview for general practice.

Yaxley JP.

J Family Med Prim Care. 2016 Jul-Sep;5(3):533-538. doi: 10.4103/2249-4863.197258. Review.

7.

A randomised control trial of salvage radiotherapy and androgen deprivation therapy following prostatectomy: commentary on five year follow-up findings.

Williams S, Yaxley JW, Coughlin GD, Gardiner RA.

Transl Androl Urol. 2016 Dec;5(6):971-973. doi: 10.21037/tau.2016.11.15. No abstract available.

8.

Review of the Diagnostic Evaluation of Renal Tubular Acidosis.

Yaxley J, Pirrone C.

Ochsner J. 2016 Winter;16(4):525-530. Review.

9.

Common Analgesic Agents and Their Roles in Analgesic Nephropathy: A Commentary on the Evidence.

Yaxley J.

Korean J Fam Med. 2016 Nov;37(6):310-316. Epub 2016 Nov 18. Review.

10.

Prescribing patterns of nebulized bronchodilators: A prospective chart review.

Yaxley JP.

J Family Med Prim Care. 2016 Apr-Jun;5(2):501-502. No abstract available.

11.

Non-steroidal anti-inflammatories and the development of analgesic nephropathy: a systematic review.

Yaxley J, Litfin T.

Ren Fail. 2016 Oct;38(9):1328-1334. Epub 2016 Aug 5. Review.

PMID:
27494231
12.

One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason grading.

Srigley JR, Delahunt B, Egevad L, Samaratunga H, Yaxley J, Evans AJ.

Can Urol Assoc J. 2016 Sep-Oct;10(9-10):339-341. Review. No abstract available.

13.

The use of 68  Ga-PSMA PET CT in men with biochemical recurrence after definitive treatment of acinar prostate cancer.

Meredith G, Wong D, Yaxley J, Coughlin G, Thompson L, Kua B, Gianduzzo T.

BJU Int. 2016 Oct;118 Suppl 3:49-55. doi: 10.1111/bju.13616. Epub 2016 Sep 23.

PMID:
27659411
14.

A Cost-Utility Analysis of Prostate Cancer Screening in Australia.

Keller A, Gericke C, Whitty JA, Yaxley J, Kua B, Coughlin G, Gianduzzo T.

Appl Health Econ Health Policy. 2017 Feb;15(1):95-111. doi: 10.1007/s40258-016-0278-6.

PMID:
27757918
15.

Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia.

Gordon LG, James R, Tuffaha HW, Lowe A, Yaxley J.

J Magn Reson Imaging. 2017 May;45(5):1304-1315. doi: 10.1002/jmri.25504. Epub 2016 Oct 11.

PMID:
27726240
16.

Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers.

Roberts MJ, Richards RS, Chow CW, Doi SA, Schirra HJ, Buck M, Samaratunga H, Perry-Keene J, Payton D, Yaxley J, Lavin MF, Gardiner RA.

Prostate Int. 2016 Sep;4(3):97-102. doi: 10.1016/j.prnil.2016.04.002. Epub 2016 May 5.

17.

Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years.

Yaxley JW, Lah K, Yaxley JP, Gardiner RA, Samaratunga H, MacKean J.

BJU Int. 2016 Sep 15. doi: 10.1111/bju.13659. [Epub ahead of print]

PMID:
27628127
18.

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study.

Yaxley JW, Coughlin GD, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, Dunglison N, Carter R, Williams S, Payton DJ, Perry-Keene J, Lavin MF, Gardiner RA.

Lancet. 2016 Sep 10;388(10049):1057-1066. doi: 10.1016/S0140-6736(16)30592-X. Epub 2016 Jul 26.

PMID:
27474375
19.

From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.

Samaratunga H, Delahunt B, Yaxley J, Srigley JR, Egevad L.

Scand J Urol. 2016 Oct;50(5):325-9. doi: 10.1080/21681805.2016.1201858. Epub 2016 Jul 14.

PMID:
27415753
20.

Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol.

Roberts MJ, Yaxley JW, Coughlin GD, Gianduzzo TR, Esler RC, Dunglison NT, Chambers SK, Medcraft RJ, Chow CW, Schirra HJ, Richards RS, Kienzle N, Lu M, Brereton I, Samaratunga H, Perry-Keene J, Payton D, Oyama C, Doi SA, Lavin MF, Gardiner RA.

Contemp Clin Trials. 2016 Sep;50:16-20. doi: 10.1016/j.cct.2016.06.014. Epub 2016 Jun 28.

PMID:
27370230

Supplemental Content

Loading ...
Support Center